Curtis Oltmans

Array BioPharma

General Counsel

Annual data

2018

In 2018, Curtis Oltmans earned a total compensation of $4M as General Counsel at Array BioPharma.

Ranking2,333 out of 11,002
Percentile78.8%

Curtis Oltmans' 2018 compensation ranked 2,333rd out of 11,002 executive pay records tracked by us this year.

Oltmans earned more than 78.8% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking235 out of 1,265
Percentile81.4%

In the industry group of Drugs, Oltmans' pay ranked 235th out of 1,265 executive pay records tracked by us in 2018.

Oltmans earned more than 81.4% of executives in this group.

Bonus$5,000
Non-Equity Incentive Plan$154,604
Option Awards$2,984,581
Salary$351,538
Stock Awards$305,760
Other$171,861
Total$3,973,344

Oltmans received $3M in option awards, which accounts for 75.12% of total compensation.

Oltmans also received $5K in bonus, $154.6K in non-equity incentive plan, $351.5K in salary, $305.8K in stock awards and $171.9K in other compensation.